ReviewTherapeutic advances in cardiovascular disease
Sodium glucose cotransporter (SGLT)-2 inhibitors alleviate the renal stress responsible for sympathetic activation.
Motoaki SanoPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
pooled ittrialcites it